DE60014885T2 - Amphiphile cyclodextrine, deren herstellung und verwendung zur auflösung von strukturierten systemen und zur einbettung von hydrophoben verbindungen - Google Patents

Amphiphile cyclodextrine, deren herstellung und verwendung zur auflösung von strukturierten systemen und zur einbettung von hydrophoben verbindungen Download PDF

Info

Publication number
DE60014885T2
DE60014885T2 DE60014885T DE60014885T DE60014885T2 DE 60014885 T2 DE60014885 T2 DE 60014885T2 DE 60014885 T DE60014885 T DE 60014885T DE 60014885 T DE60014885 T DE 60014885T DE 60014885 T2 DE60014885 T2 DE 60014885T2
Authority
DE
Germany
Prior art keywords
radicals
formula
derivative
cyclodextrin
cyclodextrin derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60014885T
Other languages
German (de)
English (en)
Other versions
DE60014885D1 (de
Inventor
Rachel Auzely-Velty
Bruno Perly
Florence Djedaini-Pilard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Commissariat à l'Énergie Atomique et Aux Énergies Alternatives
Original Assignee
Commissariat a lEnergie Atomique CEA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commissariat a lEnergie Atomique CEA filed Critical Commissariat a lEnergie Atomique CEA
Publication of DE60014885D1 publication Critical patent/DE60014885D1/de
Application granted granted Critical
Publication of DE60014885T2 publication Critical patent/DE60014885T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nanotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Optics & Photonics (AREA)
  • Medical Informatics (AREA)
  • Physics & Mathematics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
DE60014885T 1999-04-29 2000-04-26 Amphiphile cyclodextrine, deren herstellung und verwendung zur auflösung von strukturierten systemen und zur einbettung von hydrophoben verbindungen Expired - Lifetime DE60014885T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9905460 1999-04-29
FR9905460A FR2792942B1 (fr) 1999-04-29 1999-04-29 Cyclodextrines amphiphiles, leur preparation et leur utilisation pour solubiliser des systemes organises et incorporer des molecules hydrophobes
PCT/FR2000/001102 WO2000066635A1 (fr) 1999-04-29 2000-04-26 Cyclodextrines amphiphiles, leur preparation et leur utilisation pour solubiliser des systemes organises et incorporer des molecules hydrophobes

Publications (2)

Publication Number Publication Date
DE60014885D1 DE60014885D1 (de) 2004-11-18
DE60014885T2 true DE60014885T2 (de) 2005-10-27

Family

ID=9545038

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60014885T Expired - Lifetime DE60014885T2 (de) 1999-04-29 2000-04-26 Amphiphile cyclodextrine, deren herstellung und verwendung zur auflösung von strukturierten systemen und zur einbettung von hydrophoben verbindungen

Country Status (7)

Country Link
US (1) US6858723B1 (enExample)
EP (1) EP1177217B1 (enExample)
JP (1) JP4698842B2 (enExample)
AT (1) ATE279446T1 (enExample)
DE (1) DE60014885T2 (enExample)
FR (1) FR2792942B1 (enExample)
WO (1) WO2000066635A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004022100A1 (en) * 2002-08-15 2004-03-18 Yunqing Liu Soild nano pharmaceutical formulation and preparation method thereof
KR20140070676A (ko) * 2002-09-06 2014-06-10 인설트 테라페틱스, 인코퍼레이티드 공유결합된 치료제 전달을 위한 사이클로덱스트린-기초 중합체
FR2850972B1 (fr) * 2003-02-07 2005-03-11 Commissariat Energie Atomique Derives de per(3,6-anhydro) cyclodextrines, leur preparation et leur utilisation pour vehiculer des elements metalliques vers des cibles biologiques ou pour decontaminer des cibles ou fluides biologiques
FR2861396B1 (fr) * 2003-10-24 2005-12-16 Commissariat Energie Atomique Derives amphiphiles de cyclodextrines,leur procede de preparation et leurs utilisations
CN1894283B (zh) * 2003-12-18 2012-07-04 西巴特殊化学品控股有限公司 反应性多糖衍生物、其制备及其用途
EP1735326A4 (en) * 2004-01-29 2011-04-20 Pinnacle Pharmaceuticals BETA-CYCLODEXTRIN DERIVATIVES AND THEIR USE AGAINST LETHAL ANTHRAX TOXIN
CN101151037A (zh) * 2005-01-28 2008-03-26 平纳克尔医药股份有限公司 作为抗菌剂的β-环糊精衍生物
EP2023896B8 (en) * 2006-05-19 2016-09-14 Viroblock SA A composition for inactivating an enveloped virus
FR2907455A1 (fr) * 2006-10-18 2008-04-25 Commissariat Energie Atomique Oligosaccharides cycliques,notamment derives de cyclodextrines amphiphiles,substitues par un ou plusieurs groupements polycycles naturels,tels que les triterpenoides.
US20080176958A1 (en) 2007-01-24 2008-07-24 Insert Therapeutics, Inc. Cyclodextrin-based polymers for therapeutics delivery
FR2919872B1 (fr) * 2007-08-10 2009-12-18 Commissariat Energie Atomique Derives de cyclodextrines
JP5364923B2 (ja) * 2009-01-28 2013-12-11 学校法人福岡大学 多機能性シクロデキストリン誘導体、その包接化合物およびそれらの製造方法。
WO2014055493A1 (en) 2012-10-02 2014-04-10 Cerulean Pharma Inc. Methods and systems for polymer precipitation and generation of particles
US9051479B2 (en) * 2012-10-12 2015-06-09 Empire Technology Development Llc Paints and coatings containing cyclodextrin additives
CN105392804B (zh) * 2013-08-09 2018-07-10 生物辐射实验室股份有限公司 采用修饰的环糊精的蛋白质检测
TW202009013A (zh) * 2018-08-14 2020-03-01 優你康光學股份有限公司 具有功能性成分的隱形眼鏡及其產品
US20220362401A1 (en) * 2019-09-20 2022-11-17 The University Of Kitakyushu Particles, method for producing particles, drug, method for producing drug, and anti-cancer agent

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2681868A1 (fr) * 1991-09-30 1993-04-02 Sederma Sa Nouvelles substances amphiphiles derivees de cyclodextrines et leur utilisation dans des compositions cosmetiques.
FR2726765B1 (fr) 1994-11-14 1996-12-20 Cis Bio Int Compositions radiopharmaceutiques comprenant un complexe d'inclusion d'une cyclodextrine et d'un acide gras radiohalogene
FR2736056B1 (fr) * 1995-06-29 1997-08-08 Commissariat Energie Atomique Derives de cyclodextrines, leur preparation et leur utilisation pour incorporer des molecules hydrophobes dans des systemes de tensioactifs organises
WO2002055562A2 (en) * 2001-01-11 2002-07-18 Eastman Chem Co Cyclodextrin sulfonates, guest inclusion complexes, methods of making the same and related materials

Also Published As

Publication number Publication date
JP4698842B2 (ja) 2011-06-08
EP1177217B1 (fr) 2004-10-13
ATE279446T1 (de) 2004-10-15
JP2002543249A (ja) 2002-12-17
EP1177217A1 (fr) 2002-02-06
DE60014885D1 (de) 2004-11-18
FR2792942B1 (fr) 2001-06-08
FR2792942A1 (fr) 2000-11-03
WO2000066635A1 (fr) 2000-11-09
US6858723B1 (en) 2005-02-22

Similar Documents

Publication Publication Date Title
DE10033990B4 (de) Nanopartikel aus einem substituierten Cyclodextrin, dessen Verwendung und diese enthaltenden Zubereitungen
DE69525639T2 (de) Herstellung kleiner partikel
EP0214647B1 (de) Inklusionskomplexe von 7-Isopropoxy-isoflavon mit Cyclodextrinen, Verfahren zu deren Herstellung und diese Inklusionskomplexe enthaltende pharmazeutische Präparate
EP0078820B1 (de) Inklusionscomplexe von n-(1-phenyläthyl)-3,3-diphenylpropylamin bzw. dessen hydrochlorid mit cyclodextrin, verfahren zur herstellung dieser inklusionskomplexe sowie diese inklusionskomplexe enthaltende pharmazeutische präparate
DE2712030C2 (de) Entzündungshemmende pharmazeutische Zusammensetzung mit einem Gehalt an Liposomen
DE69331900T3 (de) Cyclodextrinderivate mit erhöhter wasserlösichkeit und deren verwendung
US5166139A (en) Complexes of saponins and their aglycons with phospholipids and pharmaceutical and cosmetic compositions containing them
DE69305808T2 (de) Mindestens ein Salicylsäurederivat enthaltende Zusammensetzung für die Behandlung von Akne
DE69410118T2 (de) CYCLODEXTRINDERIVATE ZUR AUFLöSUNG VON HYDROPHOBEN, CHEMISCHEN VERBINDUNGEN WIE ARZNEIMITTELN; VERFAHREN ZU DEREN HERSTELLUNG
DE69730902T2 (de) Verfahren zur Selektion eines Salzes zur Herstellung eines Inklusionskomplexes
DE69733651T2 (de) Lipid a-analoge enthaltende injektionen und verfahren zu deren herstellung
DE19637433B4 (de) Metall-eingekapselte Fullerenverbindung und Verfahren zu deren Herstellung
DE60208454T2 (de) Polyalkylenoxid-modifizierte Phospholipide und Verfahren zu ihrer Herstellung
EP1177217B1 (fr) Cyclodextrines amphiphiles, leur preparation et leur utilisation pour solubiliser des systemes organises et incorporer des molecules hydrophobes
DE102008030992A1 (de) Linear-dendritische Polyglycerolverbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung
DE68904999T2 (de) Verfahren zur herstellung dispergierbarer kolloidaler systeme aus amphiphilen lipiden in form von liposomen in submikrongroesse.
DE19747600C2 (de) Nichtionische Vitamin E-Derivate oder polyethoxylierte Vitamin E-Derivate und Verfahren zu ihrer Herstellung sowie ihre Verwendung
DE69025691T2 (de) Einschlusskomplexe mit Silybinin, ihre Herstellung und pharmazeutische Präparate, die diese enthalten
EP0707847A1 (de) Ketoprofen Liposomen
DE69820861T2 (de) Teilchenförmige arzneimittelträger
DE3238800A1 (de) Mit (gamma)-cyclodextrin gebildete einschlusskomplexe von steroidverbindungen, verfahren zu ihrer herstellung und diese einschlusskomplexe enthaltende arzneimittelpraeparate
DE69225049T2 (de) Herstellungsverfahren für teilchen in submikrongrösse in gegenwart von lipidvesikeln sowie die entsprechenden zusammensetzungen
EP0490193A1 (de) Komplexe des aktiven Enantiomers des Ibuprofens mit Cyclodextrin
EP0749447A1 (de) Wasserlösliche dextranfettsäureester und ihre verwendung als solubilisatoren
DE60004768T2 (de) Komplexe von paroxetin mit cyclodextrin oder cyclodextrin derivaten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition